affects approximately 1 in 3000 people.1 Unlike other neurocutaneous disorders such as tuberous sclerosis, epilepsy is not a common clinical feature, occurring in 3.8-7% of NF1 patients.2 Rarely, case reports have described patients with NF1 and epilepsy due to malformations of cortical development...
Epilepsy affects approximately 50 million people across the globe, with an estimated 5 million new cases being diagnosed each year1. Many types of epilepsy are associated with cognitive impairment2. In addition, epilepsy can severely affect an individual’s quality of life and ability to function....
Epilepsy is one of the most common nervous or mental diseases, affecting approximately 0.5–1 percent of the population. It generally occurs between the ages of 10 and 15 years. The various forms of epilepsy were traditionally divided into two groups. Cases of unknown origin, or cause, were ...
Epilepsy, a brain disorder that causes recurring, unprovoked seizures, affects approximately 3.4 million people in the U.S., according to the Epilepsy Foundation. For those newly diagnosed, understanding the condition and its impact on daily life can feel overwhelming and frightening. Firas Bannout,...
Epilepsy affects approximately 40,000 people in Ireland, with one in three people unable to control seizures through medication. For these individuals, surgical intervention is often the best option, but its success hinges on accurately mapping the regions responsible for seizure activity. ...
Epilepsy affects approximately 3 million people in the USA and up to 2% of the worldwide population. The yearly direct medical cost of epilepsy in the USA alone is estimated to be $9.5 billion. Epilepsy affects both children and adults and can significantly impair quality of life. Zonisamide ...
Drug-resistant epilepsy (DRE) affects approximately one third of epileptic patients. Among various theories that try to explain multidrug resistance, the transporter hypothesis is the most extensively studied. Accordingly, the overexpression of efflux transporters in the blood-brain barrier (BBB), mainly...
Disorders in brain metabolism and seizures may interact, exacerbating the condition. The current global prevalence of inborn errors of metabolism is approximately 1 in 2000 people, with 20–30% of individuals experiencing epilepsy as their primary neurological manifestation [2]. Oral antiseizure ...
Approximately 1 in 6000 births will be affected by TSC.1 How Is TSC Diagnosed? Because it is a genetic disorder, TSC can affect any tissue or organ system in the body. Different parts of the body are more or less commonly affected, and some manifestat...
Epilepsy affects approximately 14 to 24% of patients who are mentally retarded. The prevalence increases in those patients who have associated neurological... DS Deb - 《Cns Drugs》 被引量: 50发表: 2000年 Aetiology and treatment of epilepsy in a series of... [Aetiology and treatment of epile...